These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7511758)

  • 21. Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril.
    Elliott HL; Macdonald NJ; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1992 Mar; 51(3):260-5. PubMed ID: 1312002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal protective effects of angiotensin converting enzyme inhibitors.
    Weder AB
    Am J Hypertens; 1990 Nov; 3(11):273S-277S. PubMed ID: 2261145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats.
    Petitjean P; Vloemans M; Barthelmebs M; Stephan D; Grima M; Jund A; Imbs JL
    Fundam Clin Pharmacol; 1994; 8(4):356-65. PubMed ID: 7851841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR.
    Numabe A; Komatsu K; Frohlich ED
    Am J Physiol; 1994 May; 266(5 Pt 2):R1437-42. PubMed ID: 8203617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor.
    Fabris B; Candido R; Carraro M; Fior F; Artero M; Zennaro C; Cattin MR; Fiorotto A; Bortoletto M; Millevoi C; Bardelli M; Faccini L; Carretta R
    Diabetes; 2001 Nov; 50(11):2619-24. PubMed ID: 11679443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinapril: a new second-generation ACE inhibitor.
    Cetnarowski-Cropp AB
    DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S
    Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
    Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
    Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats.
    Mori T; Nishimura H; Okabe M; Ueyama M; Kubota J; Kawamura K
    Eur J Pharmacol; 1998 May; 348(2-3):229-34. PubMed ID: 9652338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
    Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
    Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
    Vacher E; Fornes P; Domergue V; Richer C; Bruneval P; Giudicelli JF
    Am J Hypertens; 1993 Nov; 6(11 Pt 1):951-9. PubMed ID: 8305170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.
    Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K
    Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.
    Munger MA; Chance M; Nair R; Prescott AW; Nara AR; Simonson MS; Green JA; Posvar EL
    J Clin Pharmacol; 1992 Jan; 32(1):70-6. PubMed ID: 1740540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.
    Begg EJ; Robson RA; Bailey RR; Lynn KL; Frank GJ; Olson SC
    Br J Clin Pharmacol; 1990 Aug; 30(2):213-20. PubMed ID: 2144994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.